1 recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow hydrocortisone sodium phosphate: new trials by email Literature Review of hydrocortisone sodium phosphate trials Research Report on hydrocortisone sodium phosphate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax Basket Trial for High Risk Hematologic Malignancies Venetoclax, Azacitidine, Cytarabine - Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary | Phase 1 | Recruiting | Andrew E. Place, MD | 30 | 2023-03-29 | 2026-03-12 |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) EZN-3042, Cytarabine, Doxorubicin - Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood | Phase 1 | Terminated | Therapeutic Advances in Childhood Leukemia Consortium | 6 | 2010-08-24 | 2024-02-01 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Recurrence (2) · Leukemia (1) · Leukemia, Biphenotypic, Acute (1) · Myelodysplastic Syndromes (1) · Neoplasm Metastasis (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Andrew E. Place, MD (1) · Therapeutic Advances in Childhood Leukemia Consortium (1)
United States (2) · Australia (1)
Andrew E Place, MD, PhD (1) · Elizabeth Raetz, MD (1) · William Carroll, MD (1)